Lifetime risk of ESRD

Journal of the American Society of Nephrology

Volumn 23, Issue 9, 2012, Pages 1569-1578

  Turin, Tanvir Chowdhury ^a   Tonelli, Marcello ^b   Manns, Braden J ^a   Ahmed, Sofia B ^a   Ravani, Pietro ^a   James, Matthew ^a   Hemmelgarn, Brenda R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DEATH; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE POLICY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 84865997207     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012020164     Document Type: Article

References (30)

1. US Renal Data System: USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, 2007. Available at: http://www.usrds.org/adr.htm. Accessed January 15, 2012.
2. Zoccali CKramer A, Jager KJ: Chronic kidney disease and end-stage renal disease - a review produced to contribute to the report 'the status of health in the European union: Towards a healthier Europe.' NDT Plus 3: 213-224, 2010
3. Zelmer JL: The economic burden of end-stage renal disease in Canada. Kidney Int 72: 1122-1129, 2007
4. Edwards A, Elwyn G, Mulley A: Explaining risks: turning numerical data into meaningful pictures. BMJ 324: 827-830, 2002 (Pubitemid 34280736)
5. Turin TC, Kokubo Y, Murakami Y, Higashiyama A, Rumana N, Watanabe M, Okamura T: Lifetime risk of acute myocardial infarction in Japan. Circ Cardiovasc Qual Outcomes 3: 701-703, 2010
6. Lloyd-Jones DM, Larson MG, Beiser A, Levy D: Lifetime risk of developing coronary heart disease. Lancet 353: 89-92, 1999 (Pubitemid 29088076)
7. Turin TC, Kokubo Y, Murakami Y, Higashiyama A, Rumana N, Watanabe M, Okamura T: Lifetime risk of stroke in Japan. Stroke 41: 1552-1554, 2010
8. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA: The lifetime risk of stroke: Estimates from the Framingham Study. Stroke 37: 345-350, 2006 (Pubitemid 43731985)
9. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D: Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 287: 1003-1010, 2002 (Pubitemid 34252058)
10. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 290: 1884-1890, 2003 (Pubitemid 37430605)
11. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T: The lifetime risk of developing breast cancer. J Natl Cancer Inst 85: 892-897, 1993 (Pubitemid 23157129)
12. Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, D'Agostino RB: Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology 49: 1498-1504, 1997 (Pubitemid 28015107)
13. Cummings SR, Black DM, Rubin SM: Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white post-menopausal women. Arch Intern Med 149: 2445-2448, 1989 (Pubitemid 19283200)
14. Lauritzen JB, Schwarz P, Lund B, McNair P, Transbøl I: Changing incidence and residual lifetime risk of common osteoporosis-related fractures. Osteoporos Int 3: 127-132, 1993 (Pubitemid 23125373)
15. Kiberd BA, Clase CM: Cumulative risk for developing end-stage renal disease in the US population. J Am Soc Nephrol 13: 1635-1644, 2002 (Pubitemid 34579252)
16. Baigent C, Burbury K, Wheeler D: Premature cardiovascular disease in chronic renal failure. Lancet 356: 147-152, 2000 (Pubitemid 30438520)
17. Lysaght MJ: Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 13[Suppl 1]: S37-S40, 2002
18. Eriksen BO, Ingebretsen OC: The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int 69: 375-382, 2006 (Pubitemid 43323090)
19. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 11: 319-329, 2000 (Pubitemid 30064855)
20. Seliger SL, Davis C, Stehman-Breen C: Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 10: 219-225, 2001 (Pubitemid 32221764)
21. Berry SD, Ngo L, Samelson EJ, Kiel DP: Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 58: 783-787, 2010
22. Schwartz LM, Woloshin S, Welch HG: Risk communication in clinical practice: Putting cancer in context. J Natl Cancer Inst Monogr 25: 124-133, 1999
23. Fortin JM, Hirota LK, Bond BE, O'Connor AM, Col NF: Identifying patient preferences for communicating risk estimates: A descriptive pilot study. BMC Med Inform Decis Mak 1: 2, 2001
24. National Center for Health Statistics: Healthy People 2000 Review, 1995-96, Hyattsville, MD, Public Health Service, 1996
25. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M: Overview of the Alberta Kidney Disease Network. BMC Nephrol 10: 30, 2009
26. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
27. Manns BJ, Mortis GP, Taub KJ, McLaughlin K, Donaldson C, Ghali WA: The Southern Alberta Renal Program database: A prototype for patient management and research initiatives. Clin Invest Med 24: 164-170, 2001 (Pubitemid 32912362)
28. Clement FM, James MT, Chin R, Klarenbach SW, Manns BJ, Quinn RR, Ravani P, Tonelli M, Hemmelgarn BR; Alberta Kidney Disease Network: Validation of a case definition to define chronic dialysis using outpatient administrative data. BMC Med Res Methodol 11: 25, 2011
29. Beiser A, D'Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA: Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med 19: 1495-1522, 2000 (Pubitemid 30346242)
30. Driver JA, Djoussé L, Logroscino G, Gaziano JM, Kurth T: Incidence of cardiovascular disease and cancer in advanced age: Prospective cohort study. BMJ 337: a2467, 2008